Reminder: Invitation to Roche’s virtual event following ASH 2023 Dienstag, 05. Dezember 2023 - 10:26

We are pleased to invite investors and analysts to participate in our virtual event on Tuesday,

12 December 2023, highlighting Roche data presented at the 65th American Society of Hematology Annual Meeting and Exposition, from 9th to 12th December, 2023.

18:00 - 19:00 CET / 17:00 - 18:00 GMT

12:00 pm - 01:00 pm EST / 9:00 - 10:00 am PST

The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 17:00 CET on the day of the event. >click here

Agenda

Welcome
Bruno Eschli, Head of Investor Relations

Roche hematology strategy
Peter Ahnesorg, Franchise Head Hematology

Review of key data presented at ASH
Charles Fuchs, Senior Vice President - Global Head of Oncology and Hematology Product Development

Q&A

Access to virtual event (pre-registration required)

Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Sabine Borngräber
Investor Relations Officer

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Dr. Gerard Tobin

Phone: +41 61 68-72942

e-mail: gerard.tobin@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com